Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment in Patients With EGFR Wild-Type Non-Small-Cell Lung Cancer: The Never-Ending Story

被引：13
作者：
Gelsomino, Francesco [1 ]
Agustoni, Francesco [1 ]
Niger, Monica [1 ]
Valota, Marika [1 ]
Haspinger, Eva R. [1 ]
机构：
[1] Ist Nazl Tumori, Fdn Ist Ricovero & Cura Carattere Sci, I-20133 Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 26期
关键词：
PHASE-III TRIAL; PLATINUM-BASED CHEMOTHERAPY; DOUBLE-BLIND; OPEN-LABEL; MAINTENANCE THERAPY; 1ST-LINE ERLOTINIB; 2ND-LINE TREATMENT; GEFITINIB; MULTICENTER; PLACEBO;
D O I：
10.1200/JCO.2013.50.2617
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3291 / 3293
页数：3
相关论文
共 29 条
  • [1] [Anonymous], J CLIN ONCOL S15
  • [2] Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study
    Cappuzzo, Federico
    Ciuleanu, Tudor
    Stelmakh, Lilia
    Cicenas, Saulius
    Szczesna, Aleksandra
    Juhasz, Erzsebet
    Esteban, Emilio
    Molinier, Olivier
    Brugger, Wolfram
    Melezinek, Ivan
    Klingelschmitt, Gaelle
    Klughammer, Barbara
    Giaccone, Giuseppe
    [J]. LANCET ONCOLOGY, 2010, 11 (06) : 521 - 529
  • [3] Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study
    Ciuleanu, Tudor
    Stelmakh, Lilia
    Cicenas, Saulius
    Miliauskas, Skaidrius
    Grigorescu, Alexandru Calin
    Hillenbach, Carina
    Johannsdottir, Hrefna Kristin
    Klughammer, Barbara
    Esteban Gonzalez, Emilio
    [J]. LANCET ONCOLOGY, 2012, 13 (03) : 300 - 308
  • [4] Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial
    Douillard, Jean-Yves
    Shepherd, Frances A.
    Hirsh, Vera
    Mok, Tony
    Socinski, Mark A.
    Gervais, Radj
    Liao, Mei-Lin
    Bischoff, Helge
    Reck, Martin
    Sellers, Mark V.
    Watkins, Claire L.
    Speake, Georgina
    Armour, Alison A.
    Kim, Edward S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (05) : 744 - 752
  • [5] A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)
    Gaafar, Rabab M.
    Surmont, Veerle F.
    Scagliotti, Giorgio V.
    Van Klaveren, Rob J.
    Papamichael, Demetris
    Welch, John J.
    Hasan, Baktiar
    Torri, Valter
    van Meerbeeck, Jan P.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 (15) : 2331 - 2340
  • [6] Testing Epidermal Growth Factor Receptor Mutations in Patients With Non-Small-Cell Lung Cancer to Choose Chemotherapy: The Other Side of the Coin
    Garassino, Marina Chiara
    Marsoni, Silvia
    Floriani, Irene
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (28) : 3835 - 3837
  • [7] Garassino MC, 2012, J CLIN ONCOL S, V30, p480s
  • [8] Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: The Tarceva Lung Cancer Investigation Trial
    Gatzemeier, Ulrich
    Pluzanska, Anna
    Szczesna, Aleksandra
    Kaukel, Eckhard
    Roubec, Jaromir
    De Rosa, Flavio
    Milanowski, Janusz
    Karnicka-Mlodkowski, Hanna
    Pesek, Milos
    Serwatowski, Piotr
    Ramlau, Rodryg
    Janaskova, Terezie
    Vansteenkiste, Johan
    Strausz, Janos
    Manikhas, Georgy Moiseevich
    Von Pawel, Joachim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) : 1545 - 1552
  • [9] First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer: The TORCH Randomized Trial
    Gridelli, Cesare
    Ciardiello, Fortunato
    Gallo, Ciro
    Feld, Ronald
    Butts, Charles
    Gebbia, Vittorio
    Maione, Paolo
    Morgillo, Floriana
    Genestreti, Giovenzio
    Favaretto, Adolfo
    Leighl, Natasha
    Wierzbicki, Rafal
    Cinieri, Saverio
    Alam, Yasmin
    Siena, Salvatore
    Tortora, Giampaolo
    Felletti, Raffaella
    Riccardi, Ferdinando
    Mancuso, Gianfranco
    Rossi, Antonio
    Cantile, Flavia
    Tsao, Ming-Sound
    Saieg, Mauro
    Santos, Gilda da Cunha
    Piccirillo, Maria Carmela
    Di Maio, Massimo
    Morabito, Alessandro
    Perrone, Francesco
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (24) : 3002 - 3011
  • [10] First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung
    Han, Ji-Youn
    Park, Keunchil
    Kim, Sang-We
    Lee, Dae Ho
    Kim, Hyae Young
    Kim, Heung Tae
    Ahn, Myung Ju
    Yun, Tak
    Ahn, Jin Seok
    Suh, Cheolwon
    Lee, Jung-Shin
    Yoon, Sung Jin
    Han, Jong Hee
    Lee, Jae Won
    Jo, Sook Jung
    Lee, Jin Soo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (10) : 1122 - 1128
123